Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents

J Med Chem. 2005 Jun 2;48(11):3663-79. doi: 10.1021/jm040190e.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Biological Availability
  • Dopamine Agonists / pharmacokinetics
  • Dopamine Agonists / pharmacology*
  • Dopamine Agonists / therapeutic use
  • Dopamine Antagonists / pharmacokinetics
  • Dopamine Antagonists / pharmacology*
  • Dopamine Antagonists / therapeutic use
  • Dopamine D2 Receptor Antagonists*
  • Humans
  • Receptors, Dopamine D2 / agonists*
  • Receptors, Dopamine D3
  • Structure-Activity Relationship
  • Substance-Related Disorders / drug therapy*

Substances

  • DRD3 protein, human
  • Dopamine Agonists
  • Dopamine Antagonists
  • Dopamine D2 Receptor Antagonists
  • Receptors, Dopamine D2
  • Receptors, Dopamine D3